| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 95,383 | 90,836 | 67,986 | | Cost of Revenue | 47,168 | 44,428 | 32,251 | | | Gross Profit | 48,215 | 46,408 | 35,735 | | | Operating Expenses | | Research Development | 6,665 | 7,973 | 6,234 | | Selling General and Administrative | 44,291 | 43,201 | 32,615 | | Non Recurring | 3,348 | (595) |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,089) | (4,171) | (3,114) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (402) | 223 | 1,014 | | Earnings Before Interest And Taxes | (6,448) | (3,948) | (2,294) | | Interest Expense | 397 | 705 | 249 | | Income Before Tax | (6,845) | (4,653) | (2,543) | | Income Tax Expense | 538 | 5,883 | (965) | | Minority Interest | 220 | (6) | 49 | | | | Net Income From Continuing Ops | (7,163) | (10,542) | (1,529) | | | Non-recurring Events | | Discontinued Operations | 11 | (4,154) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (7,152) | (14,696) | (1,529) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,152) | ($14,696) | ($1,529) |
|
0.51% Nasdaq 
Income Statement
